| 0.0033 Data as of May 21 |  0.00 / 0.00%Today’s Change | 0.00 Today|||52-Week Range 0.00 | +120.00% Year-to-Date |
| Previous close | 0.00 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 27,274 |
| Market cap | $122.5K |
| Dividend yield | -- |
| Earnings growth (last year) | +10.53% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +418.64% |
| P/E ratio | NM |
| Price/Sales | 109.17 |
| Price/Book | -- |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $306.0K |
| Annual profit (last year) | -$12.8M |
| Net profit margin | -4,168.30% |
Sector Health Technology |
Industry Biotechnology |
Vice President- Scientific Affairs Jo-Ann B. Maltais, PhD |
Vice President- Business Development Dale L. Richardson, MBA |
Corporate headquarters Pleasanton, California |
.
